{"id":49084,"date":"2022-10-03T15:02:03","date_gmt":"2022-10-03T13:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/"},"modified":"2022-10-03T15:02:03","modified_gmt":"2022-10-03T13:02:03","slug":"soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/","title":{"rendered":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio"},"content":{"rendered":"
\n

\nNewly FDA-approved AMVUTTRA\u2122 for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults<\/i>\n<\/p>\n

FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare<\/a>—Soleo Health<\/a>, an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA\u2122<\/a> (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.\n<\/p>\n

<\/a><\/p>\n

\nSoleo Health offers newly FDA-approved AMVUTTRA injections to patients in their homes (after an evaluation and recommendation by the treating physician) or at one of its ambulatory infusion centers (AICs) nationwide. Soleo Health employs specially trained interdisciplinary teams comprised of highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors \u2013 each of whom is trained on the clinical profile and administration for AMVUTTRA.\n<\/p>\n

\n\u201cThis marks the fourth therapy Soleo Health now offers from Alnylam Pharmaceuticals\u2019 rare disease product portfolio further strengthening our ability to care for more patients living with rare disease who benefit from innovative new therapies like AMVUTTRA,\u201d said Drew Walk, Soleo Health chief executive officer.\n<\/p>\n

\nAbout Soleo Health<\/b>\n<\/p>\n

\nFrisco, Texas-based Soleo Health<\/a> is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care. Soleo Health\u2019s interdisciplinary team comprises highly experienced physician specialists, nurse practitioners, clinical pharmacists, registered nurses, reimbursement specialists and patient care ambassadors collaborating with its referring partners.\n<\/p>\n

\nThe Company optimizes patient access solutions and delivers comprehensive services, leading to quantifiable clinical and economic value, resulting in positive patient experiences. Soleo Health has 21 pharmacy locations<\/a> with national nursing coverage and pharmacy licensure in 50 states and is accredited by URAC, ACHC with Distinction in Rare Disease and Orphan Drugs and The Joint Commission. Additionally, the Company operates more than 40 infusion centers throughout the U.S.\n<\/p>\n

\nVisit www.soleohealth.com<\/a> or connect with Soleo Health on LinkedIn<\/a>, Facebook<\/a> and Twitter<\/a> for more information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSusan Turkell, 303-766-4343, sturkell@soleohealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Newly FDA-approved AMVUTTRA\u2122 for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA\u2122 (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. Soleo Health … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49084","6":"format-standard","7":"category-industry"},"yoast_head":"\nSoleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Newly FDA-approved AMVUTTRA\u2122 for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA\u2122 (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. Soleo Health ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T13:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio\",\"datePublished\":\"2022-10-03T13:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/\"},\"wordCount\":320,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005097\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/\",\"name\":\"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005097\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"datePublished\":\"2022-10-03T13:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005097\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005097\\\/en\\\/1380401\\\/21\\\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/","og_locale":"en_US","og_type":"article","og_title":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend","og_description":"Newly FDA-approved AMVUTTRA\u2122 for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA\u2122 (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. Soleo Health ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-03T13:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio","datePublished":"2022-10-03T13:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/"},"wordCount":320,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/","url":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/","name":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","datePublished":"2022-10-03T13:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221003005097\/en\/1380401\/21\/Soleo_Logo_SimplifyingComplexCare_NEW_9-2021.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/soleo-health-adds-amvuttra-vutrisiran-to-its-specialty-pharmacy-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Soleo Health Adds AMVUTTRA\u2122 (vutrisiran) to Its Specialty Pharmacy Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49084"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49084\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}